CD133(+)EpCAM(+) Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells

Background: EpCAM or CD133 has been used as the tumor initiating cells (TICs) marker in hepatocellular carcinoma (HCC). We investigated whether cells expressing with both EpCAM and CD133 surface marker were more representative for TICs in hepatocellular carcinoma Huh7 cells. Methods: Four different...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi, Yu, Dongke, Zhang, Hao, He, Hongwei, Zhang, Caixia, Zhao, Wuli, Shao, Rong-guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421230/
https://www.ncbi.nlm.nih.gov/pubmed/22904667
http://dx.doi.org/10.7150/ijbs.4454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421230/
https://www.ncbi.nlm.nih.gov/pubmed/22904667
http://dx.doi.org/10.7150/ijbs.4454

Ejemplares similares